Harbin Gloria Pharmaceuticals Co., Ltd (002437.SZ)
CNY 2.36
(-1.26%)
CNY 2.36
(-1.26%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 175.04 Million CNY | 249.64% |
| 2022 | -111.54 Million CNY | -171.24% |
| 2021 | 156.56 Million CNY | -80.05% |
| 2020 | 784.65 Million CNY | 145.01% |
| 2019 | 320.25 Million CNY | 86.13% |
| 2018 | 172.06 Million CNY | -49.68% |
| 2017 | 341.95 Million CNY | -56.07% |
| 2016 | 778.34 Million CNY | 2.1% |
| 2015 | 762.3 Million CNY | 55.21% |
| 2014 | 491.15 Million CNY | 143.88% |
| 2013 | 201.39 Million CNY | 1.96% |
| 2012 | 197.52 Million CNY | 42.48% |
| 2011 | 138.63 Million CNY | -23.5% |
| 2010 | 181.21 Million CNY | 19.42% |
| 2009 | 151.73 Million CNY | 39.56% |
| 2008 | 108.72 Million CNY | 40.69% |
| 2007 | 77.28 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 41.62 Million CNY | 135.96% |
| 2024 Q3 | 69.03 Million CNY | -5.22% |
| 2024 Q2 | 72.83 Million CNY | 74.97% |
| 2023 Q1 | 32.21 Million CNY | 109.51% |
| 2023 Q3 | 209.03 Million CNY | 991.29% |
| 2023 Q4 | -115.75 Million CNY | -155.38% |
| 2023 FY | 166.91 Million CNY | 249.64% |
| 2023 Q2 | 19.15 Million CNY | -40.54% |
| 2022 Q2 | 41.46 Million CNY | 168.46% |
| 2022 Q1 | 15.44 Million CNY | 125.4% |
| 2022 Q4 | -338.63 Million CNY | -1038.13% |
| 2022 Q3 | 36.09 Million CNY | -12.95% |
| 2022 FY | -111.54 Million CNY | -171.24% |
| 2021 Q2 | 113.17 Million CNY | 199.87% |
| 2021 FY | 156.56 Million CNY | -80.05% |
| 2021 Q3 | 5.79 Million CNY | -94.88% |
| 2021 Q1 | 37.73 Million CNY | 115.23% |
| 2021 Q4 | -60.81 Million CNY | -1149.44% |
| 2020 Q1 | 783.17 Million CNY | 127.52% |
| 2020 FY | 784.65 Million CNY | 145.01% |
| 2020 Q3 | 10.69 Million CNY | -67.65% |
| 2020 Q4 | -247.82 Million CNY | -2416.84% |
| 2020 Q2 | 33.06 Million CNY | -95.78% |
| 2019 FY | 320.25 Million CNY | 86.13% |
| 2019 Q1 | 97.97 Million CNY | 145.76% |
| 2019 Q2 | 177.37 Million CNY | 81.03% |
| 2019 Q3 | 97.59 Million CNY | -44.98% |
| 2019 Q4 | -2.84 Billion CNY | -3015.63% |
| 2018 Q2 | 173.16 Million CNY | 54.86% |
| 2018 Q3 | 101.2 Million CNY | -41.56% |
| 2018 Q1 | 111.81 Million CNY | 5010.3% |
| 2018 Q4 | -214.12 Million CNY | -311.58% |
| 2018 FY | 172.06 Million CNY | -49.68% |
| 2017 Q1 | 145.79 Million CNY | -5.65% |
| 2017 FY | 341.95 Million CNY | -56.07% |
| 2017 Q3 | 80.87 Million CNY | -28.49% |
| 2017 Q4 | 2.18 Million CNY | -97.29% |
| 2017 Q2 | 113.09 Million CNY | -22.43% |
| 2016 Q4 | 154.52 Million CNY | -31.51% |
| 2016 Q2 | 224.05 Million CNY | 28.66% |
| 2016 Q1 | 174.15 Million CNY | 3.65% |
| 2016 FY | 778.34 Million CNY | 2.1% |
| 2016 Q3 | 225.6 Million CNY | 0.69% |
| 2015 FY | 762.3 Million CNY | 55.21% |
| 2015 Q3 | 197.6 Million CNY | -20.61% |
| 2015 Q2 | 248.88 Million CNY | 68.4% |
| 2015 Q1 | 147.79 Million CNY | -4.64% |
| 2015 Q4 | 168.02 Million CNY | -14.97% |
| 2014 Q1 | 74.71 Million CNY | 5.51% |
| 2014 FY | 491.15 Million CNY | 143.88% |
| 2014 Q3 | 100.44 Million CNY | -37.61% |
| 2014 Q2 | 160.99 Million CNY | 115.49% |
| 2014 Q4 | 154.99 Million CNY | 54.3% |
| 2013 Q2 | 55.36 Million CNY | 108.23% |
| 2013 Q3 | 48.62 Million CNY | -12.18% |
| 2013 Q4 | 70.81 Million CNY | 45.63% |
| 2013 FY | 201.39 Million CNY | 1.96% |
| 2013 Q1 | 26.59 Million CNY | -65.28% |
| 2012 Q2 | 71.27 Million CNY | 207.81% |
| 2012 Q4 | 76.59 Million CNY | 189.01% |
| 2012 FY | 197.52 Million CNY | 42.48% |
| 2012 Q1 | 23.15 Million CNY | -49.76% |
| 2012 Q3 | 26.5 Million CNY | -62.82% |
| 2011 Q1 | 19.16 Million CNY | -71.43% |
| 2011 Q2 | 57.14 Million CNY | 198.21% |
| 2011 Q3 | 16.23 Million CNY | -71.6% |
| 2011 Q4 | 46.09 Million CNY | 183.98% |
| 2011 FY | 138.63 Million CNY | -23.5% |
| 2010 Q4 | 67.06 Million CNY | 62.98% |
| 2010 Q2 | 55.94 Million CNY | 228.19% |
| 2010 Q3 | 41.15 Million CNY | -26.44% |
| 2010 FY | 181.21 Million CNY | 19.42% |
| 2010 Q1 | 17.04 Million CNY | -73.66% |
| 2009 Q4 | 64.71 Million CNY | 121.39% |
| 2009 FY | 151.73 Million CNY | 39.56% |
| 2009 Q2 | 44.35 Million CNY | 230.14% |
| 2009 Q1 | 13.43 Million CNY | 0.0% |
| 2009 Q3 | 29.22 Million CNY | -34.11% |
| 2008 FY | 108.72 Million CNY | 40.69% |
| 2007 FY | 77.28 Million CNY | 0.0% |